drugset / Trial / NCT01310049

LEO 32731 - A Study in Healthy Male Subjects

NCT01310049 ↗

Phase 1 Completed 111 enrolled LEO Pharma
RandomizedSingle-groupSingle-blind

Summary

The purpose of this first-in-man trial is to determine the safety and tolerability of ascending single and multiple doses of LEO 32731 in healthy male subjects. The trial will be performed in three parts. In Part 1, single doses of LEO 32731 will be administered to healthy male subjects. In Part 2, the effect of food on the single oral dose pharmacokinetic will be investigated. In Part 3, multiple doses of LEO 32731 will be administered to healthy male subjects.

Timeline

Start
2011-03
Primary completion
2012-08
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 32731 Unknown — Oral

Indications

No indication recorded.